22 mayo 2017

PharmaMar se Presenta con Todos sus Logros y Espectativas Ante Analistas ... Bancos ... Inversores Públicos y Privados ... en la BIO€QUITY EUROPE 2017 que tendra lugar el 22 y 23 de Mayo en Paris .

Resultado de imagen de pascal besman pharmamarPharmaMar’s COO Pascal Besman at BioEquity Europe 2017 : Advice and Q&A on how to position your company to global investors .

BIO EQUITY EUROPE 2017 Reúne a Inversores Privados y Públicos, Bancos y Analistas, con Empresas Biotecnológicas de toda Europa, con el Objetivo de Expandir los Mercados de Capitales, para su Inversión en el Sector de Ciencias de la Vida en Europa. 

Bio€quity Europe pioneered the turf-neutral concept, creating an open door for all members of the financial community and business development and licensing professionals to do business with independently selected Presenting Companies.

Now celebrating its 18th meeting, Bio€quity Europe is the seminal industry event for financial dealmakers looking for investor-validated life science companies positioning themselves to attract capital, and for pharmaceutical licensing professionals to assess top prospects. Bio€quity Europe has showcased more than 700 leading European companies to thousands of investment and pharma business development professionals. Delegates from 24 nations attended Bio€quity Europe last year in Copenhagen.

Marriott Rive Gauche .

17 Boulevard Saint Jacques .
Paris 75014 France


 May 22 - 23, 2017 .


Bio€quity Europe 2017 will be anchored by more than 80 investor-validated Presenting and Next Wave Companies. 

The financial community recognizes that the Presenting Companies are independently chosen by BioCentury based on rigorous criteria, including fundraising validation and upcoming milestones informed by the intelligence of the conference's leading sponsors.